Nice HCC debate &amp; discussion by @lauren_henke!

Historically (neo)adjuvant trials in HCC have been designed around resection &amp; ablation.

W high rates of control/ablative doses achievable w rad seg &amp; SBRT, argue these modalities should also be included as definitive options #GI25
#GI25